Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sverre E Kjeldsen

Showing results (1-10 of 263) with videos related to

Pageof 27
Sort By:
Pharmacological Research|November 12, 2017
Hypertension and cardiovascular risk: General aspectsSverre E Kjeldsen
European Journal of Internal Medicine|February 15, 2015
Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972-3Ingar Holme, Sverre E Kjeldsen
Herz|July 1, 2006
Are all the hypertensives made equal?Arnljot Flaa, Sverre E Kjeldsen
Current Hypertension Reports|January 17, 2017
The Un-Observed Automated Office Blood Pressure Measurement Technique Used in the SPRINT Study Points to a Standard Target Office Systolic Blood Pressure <140 mmHgSverre E Kjeldsen, Giuseppe Mancia
American Heart Journal|November 4, 2004
Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockersSverre E Kjeldsen, Stevo Julius
Current Vascular Pharmacology|July 15, 2010
A link between hypertension and atrial fibrillation: methods of treatment and preventionTonje A Aksnes, Sverre E Kjeldsen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 24, 2005
[Uric acid--more deleterious than we thought?]Aud Høieggen, Ingrid Os, Sverre E Kjeldsen
Blood Pressure|July 3, 2023
Effect of antihypertensive treatment in isolated systolic hypertension (ISH) - systematic review and meta-analysis of randomised controlled trialsMattias Brunström, Bo Carlberg, Sverre E Kjeldsen
Kardiologia Polska|September 18, 2023
How to optimize the use of diuretics in patients with heart failure?Michel Burnier, Krzysztof Narkiewicz, Sverre E Kjeldsen
Current Hypertension Reports|May 1, 2010
The prognostic significance of heart rate for cardiovascular disease and hypertensionTrygve B Tjugen, Arnljot Flaa, Sverre E Kjeldsen
Pageof 27

Showing results (1-10 of 263) with videos related to

Sort By:
Pageof 27
Pharmacological Research|November 12, 2017
Hypertension and cardiovascular risk: General aspectsSverre E Kjeldsen
European Journal of Internal Medicine|February 15, 2015
Long-term survival in the randomized trial of drug treatment in mild to moderate hypertension of the Oslo study 1972-3Ingar Holme, Sverre E Kjeldsen
Herz|July 1, 2006
Are all the hypertensives made equal?Arnljot Flaa, Sverre E Kjeldsen
Current Hypertension Reports|January 17, 2017
The Un-Observed Automated Office Blood Pressure Measurement Technique Used in the SPRINT Study Points to a Standard Target Office Systolic Blood Pressure <140 mmHgSverre E Kjeldsen, Giuseppe Mancia
American Heart Journal|November 4, 2004
Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockersSverre E Kjeldsen, Stevo Julius
Current Vascular Pharmacology|July 15, 2010
A link between hypertension and atrial fibrillation: methods of treatment and preventionTonje A Aksnes, Sverre E Kjeldsen
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|May 24, 2005
[Uric acid--more deleterious than we thought?]Aud Høieggen, Ingrid Os, Sverre E Kjeldsen
Blood Pressure|July 3, 2023
Effect of antihypertensive treatment in isolated systolic hypertension (ISH) - systematic review and meta-analysis of randomised controlled trialsMattias Brunström, Bo Carlberg, Sverre E Kjeldsen
Kardiologia Polska|September 18, 2023
How to optimize the use of diuretics in patients with heart failure?Michel Burnier, Krzysztof Narkiewicz, Sverre E Kjeldsen
Current Hypertension Reports|May 1, 2010
The prognostic significance of heart rate for cardiovascular disease and hypertensionTrygve B Tjugen, Arnljot Flaa, Sverre E Kjeldsen
Pageof 27